Showing results (201-210 of 252) with videos related to
Sort By:
Pageof 26
The New England Journal of Medicine|November 1, 2013
Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphomaPatrick J Stiff, Joseph M Unger, James R Cook, et al.Blood|March 7, 2009
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports projectKenneth R Carson, Andrew M Evens, Elizabeth A Richey, et al.Cancers|July 29, 2025
Real World Outcomes of Patients with Aggressive Lymphoma and Autoimmune Disease Treated with CARTNicole J Altomare, Megan M Herr, Nisha M Nair, et al.Blood Cancer Journal|February 2, 2022
Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithmsMaher Albitar, Hong Zhang, Andre Goy, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 17, 2013
Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOPAlexandar Tzankov, Zijun Y Xu-Monette, Marc Gerhard, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2012
Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelinesRichard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.Journal of Hematology & Oncology|November 10, 2023
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort studyNarendranath Epperla, Lei Feng, Nirav N Shah, et al.Molecular Cancer Research : MCR|November 6, 2020
Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted AgentsManman Deng, Zijun Y Xu-Monette, Lan V Pham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2013
Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trialPhilippe Armand, Arnon Nagler, Edie A Weller, et al.Leukemia|July 27, 2017
Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapyZ Yao, L Deng, Z Y Xu-Monette, et al.Pageof 26